Related Experiment Video
Updated: May 21, 2025

16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
25.9K
Conversion between NMSS and MDS-NMS in Parkinson's Disease
Michela Garon1,2, José-Manuel Rojo-Albuin3, K Ray Chaudhuri4,5
1Padua Neuroscience Center (PNC), University of Padua, Padua, Italy.
Summary
Researchers developed conversion formulas to compare scores from the Non-Motor Symptoms Scale (NMSS) and the International Parkinson and Movement Disorder Society Non-Motor Rating Scale (MDS-NMS) in Parkinson's disease patients. These equations allow for direct data comparison across studies.
Area of Science:
- Neurology
- Clinical Assessment
- Parkinson's Disease Research
Background:
- Parkinson's disease (PD) significantly impacts patients through non-motor symptoms.
- Two key scales, the Non-Motor Symptoms Scale (NMSS) and the International Parkinson and Movement Disorder Society Non-Motor Rating Scale (MDS-NMS), assess these symptoms but differ in structure and scoring.
- This disparity hinders direct comparison of data across studies utilizing different scales.
Purpose of the Study:
- To develop reliable conversion formulas for transforming scores between the NMSS and MDS-NMS.
- To enable direct comparison and enhance data comparability for non-motor symptoms in Parkinson's disease research.
Main Methods:
- Utilized data from 402 Parkinson's disease patients from the primary MDS-NMS validation study.
- Assessed the association between domain and total scores of both scales using Spearman rank correlation and Kendall's W concordance coefficient.
- Constructed weighted linear regression models to derive equations for score transformation.
Main Results:
- Spearman rank correlations indicated moderate to strong associations between corresponding domains of the MDS-NMS and NMSS (0.39–0.88).
- Developed a formula to convert NMSS total scores to MDS-NMS total scores: MDS-NMS = 11.629 + 1.624 × NMSS (R² = 0.748).
- Developed a formula to convert MDS-NMS total scores to NMSS total scores: NMSS = 2.475 + 0.495 × MDS-NMS (R² = 0.771).
Conclusions:
- The derived conversion equations provide a robust method for interchanging scores between the NMSS and MDS-NMS.
- Facilitates enhanced data comparability across diverse research studies assessing non-motor symptoms in Parkinson's disease.
- Supports more integrated analysis and meta-analyses in the field of movement disorder research.
Related Concept Videos
Parkinson's Disease: Overview
405
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
405
Parkinson's Disease: Treatment
170
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
170
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K

